SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-24-034840
Filing Date
2024-04-22
Accepted
2024-04-22 13:53:49
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-22

Document Format Files

Seq Description Document Type Size
1 FORM ARS ea0204166-02.pdf ARS 629785
  Complete submission text file 0001213900-24-034840.txt   865684
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39138 | Film No.: 24860720
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)